Prenetics Global (PRE) Income from Continuing Operations (2021 - 2026)
Prenetics Global (PRE) posted quarterly Income from Continuing Operations of 27280000.0 for Q1 2026, down 355.58% year-over-year from 10673852.59 in Q1 2025, and down 2582.4% quarter-over-quarter from 1017000.0 in Q4 2025.
Prenetics Global (PRE) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported Income from Continuing Operations for 6 consecutive years, with 27280000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 355.58% year-over-year to 27280000.0; the TTM figure through Mar 2026 stood at 46054000.0 (up 13.04% YoY), while the FY2025 annual figure was 39396000.0, up 22.03% from the prior year.
- Income from Continuing Operations declined to 27280000.0 in Q1 2026 per PRE's latest filing, from 1017000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 4517897.0 in Q4 2022 and bottomed at 148522726.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 21481894.47 across 5 years, with a median of 12009243.0 in 2023.
- On a YoY basis, Income from Continuing Operations climbed as much as 105.11% in 2022 and fell as far as 2907.33% in 2022.
- Prenetics Global's Income from Continuing Operations stood at 4517897.0 in 2022, then tumbled by 503.48% to 18228739.0 in 2023, then tumbled by 54.82% to 28221000.0 in 2024, then jumped by 96.4% to 1017000.0 in 2025, then sank by 2582.4% to 27280000.0 in 2026.
- Business Quant data shows PRE's Income from Continuing Operations at 27280000.0 in Q1 2026, 1017000.0 in Q4 2025, and 6770000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Prenetics Global | 368.73 Mn | 309.68 Mn | 30.20 Mn | -9.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.08 Mn |
| Mar 31, 2026 | -27.28 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | -6.77 Mn |
| Jun 30, 2025 | -9.36 Mn |
| Mar 31, 2025 | -5.99 Mn |
| Dec 31, 2024 | -53.47 Mn |
| Sep 30, 2024 | -9.85 Mn |
| Jun 30, 2024 | -8.91 Mn |
| Mar 31, 2024 | -9.60 Mn |
| Dec 31, 2023 | -42.56 Mn |
| Sep 30, 2023 | -12.01 Bn |
| Jun 30, 2023 | -18.53 Bn |
| Mar 31, 2023 | -13.87 Bn |
| Dec 31, 2022 | -226.07 Mn |
| Sep 30, 2022 | -20.29 Bn |
| Jun 30, 2022 | -148.52 Bn |
| Mar 31, 2022 | 1.64 Bn |
| Dec 31, 2021 | -213.99 Bn |
| Sep 30, 2021 | -78.72 Bn |